Immunotherapy in the Republic of Korea typically costs from AUD $6,528 to AUD $12,330 per treatment cycle. Total expenses depend on the specific medication, cancer type, and required number of sessions. Patients from Australia save approximately 34% compared to local private prices, where the average cost is AUD $14,361. Fees generally cover the drug infusion, specialist consultations, and initial diagnostic monitoring.
Bookimed Expert Insight: Choosing a digital-first facility provides significant value for international patients. Seoul National University Bundang Hospital uses the BESTcare system to coordinate complex oncology data. This precision helps manage costs for high-value treatments. Large centres like Asan Medical Center handle massive patient volumes. They perform 65,000+ operations annually, ensuring high proficiency in administering advanced immunotherapy protocols safely.
| Republic of Korea | Thailand | Turkey | |
| Immunotherapy | from AUD $6,528 | from AUD $29,012 | from AUD $3,191 |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $7,543 | from AUD $11,605 | from AUD $4,787 |
| Sarcoma Immunotherapy | - | from AUD $36,265 | from AUD $26,111 |
| Immunotherapy for prostate cancer | - | from AUD $65,278 | from AUD $17,407 |
| Immunotherapy for lung cancer | - | from AUD $36,265 | from AUD $26,111 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.